The association between the level of serum 25 (OH) vitamin D, obesity, and underlying diseases with the risk of developing COVID-19 infection: a case–control study of hospitalized patients in Tehran - Abdollahi, A.; Kamali Sarvestani, H.; Rafat, Z.; Ghaderkhani, S.; Mahmoudi-Aliabadi, M.; Jafarzadeh, B. (Iran J Med Virol, 2021)

Can optimum solar radiation exposure or supplemented vitamin d intake reduce the severity of COVID-19 symptoms? - Abraham, J.; Dowling, K.; Florentine, S. (Int J Environ Res Public Health, 2021)

A network-based analysis reveals the mechanism underlying vitamin d in suppressing cytokine storm and virus in SARS-CoV-2 infection - Ahmed, F. (Front Immunol, 2020)

Assessment of vitamin d status among Egyptian covid-19 patients - Ahmed, M. A. S.; Atta, M. N. S.; Aboul-Seoud, M. A. -. L.; Tahoun, M. M.; Allah, S. (Egypt J Int Med, 2024)

Vitamin D status of black and white Americans and changes in vitamin D metabolites after varied doses of vitamin D supplementation - Alzaman, N. S.; Dawson-Hughes, B.; Nelson, J.; D’Alessio, D.; Pittas, A. G. (Am J Clin Nutr, 2016)

Does the high prevalence of vitamin D deficiency in African Americans contribute to health disparities? - Ames, B. N.; Grant, W. B.; Willett, W. C. (Nutrients, 2021)

Point of view: Should COVID-19 patients be supplemented with vitamin D? - Annweiler, C.; Cao, Z.; Sabatier, J. M. (Maturitas, 2020)

High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): a multicenter, open-label, randomized controlled superiority trial - Annweiler, C.; Beaudenon, M.; Gautier, J.; Gonsard, J.; Boucher, S.; Chapelet, G. (PLoS Med, 2022)

Vitamin D supplementation: a potential approach for coronavirus/COVID-19 therapeutics? - Arboleda, J. F.; Urcuqui-Inchima, S. (Front Immunol, 2020)

Vitamin D status and outcomes for hospitalised older patients with COVID-19 - Baktash, V.; Hosack, T.; Patel, N.; Shah, S.; Kandiah, P.; Abbeele, K. (Postgrad Med J, 2020)

Vitamin D in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients with non-invasive ventilation support - Barassi, A.; Pezzilli, R.; Mondoni, M.; Rinaldo, R. F.; DavÌ, M.; Cozzolino, M. (Panminerva Med, 2023)

Vitamin D deficiency associates with γ-tocopherol and quadriceps weakness but not inflammatory cytokines in subjects with knee osteoarthritis - Barker, T.; Henriksen, V. T.; Rogers, V. E.; Aguirre, D.; Trawick, R. H.; Lynn Rasmussen, G. (Redox Biol, 2014)

The link between COVID-19 and VItamin D (VIVID): a systematic review and meta-analysis - Bassatne, A.; Basbous, M.; Chakhtoura, M.; Zein, O.; Rahme, M.; El-Hajj Fuleihan, G. (Metab Clin Exp, 2021)

A basic review of the preliminary evidence that COVID-19 risk and severity is increased in vitamin D deficiency - Benskin, L. L. (Front Public Health, 2020)

Vitamin D deficiency and diabetes - Berridge, M. J. (Biochem J, 2017)

Vitamin D metabolism, mechanism of action, and clinical applications - Bikle, D. D. (Chem Biol, 2014)

Mechanisms in endocrinology: vitamin D and Covid-19 - Bilezikian, J. P.; Bikle, D.; Hewison, M.; Lazaretti-Castro, M.; Formenti, A. M.; Gupta, A. (Eur J Endocrinol, 2020)

Vitamin D and immune regulation: antibacterial, antiviral, anti-inflammatory - Bishop, E.; Ismailova, A.; Dimeloe, S.; Hewison, M.; White, J. H. (JBMR plus, 2021)

Vitamin D and immune regulation: antibacterial, antiviral, anti-inflammatory - Bishop, E. L.; Ismailova, A.; Dimeloe, S.; Hewison, M.; White, J. H. (JBMR Plus, 2021)

Practical recommendations for the management of diabetes in patients with COVID-19 - Bornstein, S. R.; Rubino, F.; Khunti, K.; Mingrone, G.; Hopkins, D.; Birkenfeld, A. L. (Lancet Diabetes Endocrinol, 2020)

Supplementation to prevent COVID-19 infections and deaths-accumulating evidence from epidemiological and intervention studies calls for immediate action - Brenner, H.; Vitamin, D. (Nutrients, 2021)

2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada - Brown, J. P.; Josse, R. G. (CMAJ, 2002)

Optimal nutritional status for a well-functioning immune system is an important factor to protect against viral infections - Calder, P. C.; Carr, A. C.; Gombart, A. F.; Eggersdorfer, M. (Nutrients, 2020)

Vitamin D to prevent COVID-19: recommendations for the design of clinical trials - Camargo, C. A.; Martineau, A. R. (FEBS J, 2020)

Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor - Carlberg, C.; Campbell, M. J. (Steroids, 2013)

Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19 - Carpagnano, G. E.; Lecce, V.; Quaranta, V. N.; Zito, A.; Buonamico, E.; Capozza, E. (J Endocrinol Invest, 2021)

Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: a pilot randomized clinical study - Castillo, M. E.; Costa, L. M. E.; Barrios, J. M. V.; Díaz, J. F. A.; Miranda, J. L.; Bouillon, R. (J Steroid Biochem Mol Biol, 2020)

Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital - Cereda, E.; Bogliolo, L.; Klersy, C.; Lobascio, F.; Masi, S.; Crotti, S. (Clin Nutr, 2020)

Vitamin D in COVID-19: dousing the fire or averting the storm?—A perspective from the Asia-Pacific - Chandran, M.; Chan Maung, A.; Mithal, A.; Parameswaran, R. (Osteoporos Sarcopenia, 2020)

Vitamin D and intestinal calcium absorption - Christakos, S.; Dhawan, P.; Porta, A.; Mady, L. J.; Seth, T. (Mol Cell Endocrinol, 2011)

Serum concentrations of lipids, Vitamin D metabolites, retinol, retinyl esters, tocopherols and selected carotenoids in twelve captive wild felid species at four zoos - Crissey, S. D.; Ange, K. D.; Jacobsen, K. L.; Slifka, K. A.; Bowen, P. E.; Stacewicz-Sapuntzakis, M. (J Nutr, 2003)

Obesity population at risk of COVID-19 complications - Cuschieri, S.; Grech, S. (Glob Health Epidemiol Genom, 2020)

25-Hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2 - D’Avolio, A.; Avataneo, V.; Manca, A.; Cusato, J.; Nicolò, A.; Lucchini, R. (Nutrients, 2020)

COVID-19 in age-related neurodegenerative diseases: is there a role for vitamin D3 as a possible therapeutic strategy? - Barros Viana, M.; Rosário, B. D. A.; Fátima Santana de Nazaré, M.; Estadella, D.; Ribeiro, D. A.; Socorro Barros Viana, G. (Rev Neurosci, 2021)

Implications of oxidative stress and potential role of mitochondrial dysfunction in COVID-19: therapeutic effects of vitamin D - Las, H. N.; Martín Giménez, V. M.; Ferder, L.; Manucha, W.; Lahera, V. (Antioxidants, 2020)

Serum 25 (OH) D level on hospital admission associated with COVID-19 stage and mortality - Smet, D.; Smet, K.; Herroelen, P.; Gryspeerdt, S.; Martens, G. A. (Am J Clin Pathol, 2021)

Vitamin D deficiency is associated with COVID-19 positivity and severity of the disease - Demir, M.; Demir, F.; Aygun, H. (J Med Virol, 2021)

COVID-19 in the elderly people and advances in vaccination approaches - Dhama, K.; Patel, S. K.; Natesan, S.; Vora, K. S.; Iqbal Yatoo, M.; Tiwari, R. (Hum Vaccin Immunother, 2020)

Impact of vitamin D supplementation on the clinical outcomes of COVID-19 pneumonia patients: a single-center randomized controlled trial - Dilokpattanamongkol, P.; Yan, C.; Jayanama, K.; Ngamjanyaporn, P.; Sungkanuparph, S.; Rotjanapan, P. (BMC Complement Med Ther, 2024)

Vitamin D supplementation and clinical outcomes in severe COVID-19 patients—randomized controlled trial - Domazet Bugarin, J.; Dosenovic, S.; Ilic, D.; Delic, N.; Saric, I.; Ugrina, I. (Nutrients, 2023)

Vitamin D supplementation and clinical outcomes in severe COVID-19 patients—randomized controlled trial - Domazet Bugarin, J.; Dosenovic, S.; Ilic, D.; Delic, N.; Saric, I.; Ugrina, I. (Nutrients, 2023)

Dietary supplements to reduce symptom severity and duration in people with SARS-CoV-2: a double-blind randomised controlled trial - Dugald, S.; Mark, L.; Ellen, C.; Caitlyn, K.; Athanasios, P.; Tim, R. (BMJ Open, 2023)

Vitamin D - Dusso, A. S.; Brown, A. J.; Slatopolsky, E. (Am J Physiol Renal Physiol, 2005)

Quinazolines and thiazolidine-2, 4-dions as SARS-CoV-2 inhibitors: repurposing, in silico molecular docking and dynamics simulation - El-Hddad, S. S.; Sobhy, M. H.; El-Morsy, A.; Shoman, N. A.; El-Adl, K. (RSC Adv, 2024)

Diabetes, infection risk and COVID-19 - Erener, S. (Mol Metab, 2020)

Active vitamin D supplementation and COVID-19 infections: review - Farid, N.; Rola, N.; Koch, E. A. T.; Nakhoul, N. (Irish J Med Sci, 2021)

FDA (2021a) Coronavirus (COVID-19) update: FDA authorizes first oral antiviral for treatment of COVID-19. U.S. Food and Drug Administration, December 22, 2021. Available at: https://www.fda.gov/news-events/pressannouncements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19. Accessed 1 July 2024

FDA (2021b) Coronavirus (COVID-19) update: FDA authorizes additional oral antiviral for treatment of COVID-19 in certain adults. U.S. Food and Drug Administration, December 23, 2021. Available at: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizesadditional-oral-antiviral-treatment-covid-19-certain. Accessed 1 July 2024

Vitamin D and the epigenome - Fetahu, I. S.; Höbaus, J.; Kállay, E. (Front Physiol, 2014)

Effects of vitamin D supplementation in older African American women - Gallagher, J. C.; Peacock, M.; Yalamanchili, V.; Smith, L. M. (J Clin Endocrinol Metab, 2013)

Impact of UVA exposure on psychological parameters and circulating serotonin and melatonin - Gambichler, T.; Bader, A.; Vojvodic, M.; Bechara, F. G.; Sauermann, K.; Altmeyer, P. (BMC Dermatol, 2002)

Vitamin D supplementation of initially vitamin D-deficient mice diminishes lung inflammation with limited effects on pulmonary epithelial integrity - Gorman, S.; Buckley, A. G.; Ling, K. -. M.; Berry, L. J.; Fear, V. S.; Stick, S. M. (Physiol Rep, 2017)

Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths - Grant, W. B.; Lahore, H.; McDonnell, S. L.; Baggerly, C. A.; French, C. B.; Aliano, J. L. (Nutrients, 2020)

Altered blood levels of vitamin D, cathelicidin and parathyroid hormone in patients with sepsis—a pilot study - Greulich, T.; Regner, W.; Branscheidt, M.; Herr, C.; Koczulla, A. R.; Vogelmeier, C. F. (Anaesth Intensive Care, 2017)

Vitamin D and COVID-19: evidence and recommendations for supplementation - Griffin, G.; Hewison, M.; Hopkin, J.; Kenny, R.; Quinton, R.; Rhodes, J. (R Soc Open Sci, 2020)

Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the national health and nutrition examination survey - Gutiérrez, O. M.; Farwell, W. R.; Kermah, D.; Taylor, E. N. (Osteoporos Int, 2011)

Magnesium absorption: mechanisms and the influence of vitamin D, calcium and phosphate - Hardwick, L. L.; Jones, M. R.; Brautbar, N.; Lee, D. B. (J Nutr, 1991)

Risk assessment for vitamin D - Hathcock, J. N.; Shao, A.; Vieth, R.; Heaney, R. (Am J Clin Nutr, 2007)

The vitamin D hormone and its nuclear receptor: molecular actions and disease states - Haussler, M. R.; Haussler, C. A.; Jurutka, P. W.; Thompson, P. D.; Hsieh, J. C.; Remus, L. S. (J Endocrinol, 1997)

Vitamin D and magnesium absorption in man - Hodgkinson, A.; Marshall, D. H.; Nordin, B. E. (Clin Sci, 1979)

Vitamin D deficiency - Holick, M. F. (N Engl J Med, 2007)

Skin as the site of vitamin D synthesis and target tissue for 1,25-dihydroxyvitamin D3. Use of calcitriol (1,25-dihydroxyvitamin D3) for treatment of psoriasis - Holick, M. F.; Smith, E.; Pincus, S. (Arch Dermatol, 1987)

Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline - Holick, M. F.; Binkley, N. C.; Bischoff-Ferrari, H. A.; Gordon, C. M.; Hanley, D. A.; Heaney, R. P. (J Clin Endocrinol Metab, 2011)

Vitamin D for health: a global perspective - Hossein-nezhad, A.; Holick, M. F. (Mayo Clin Proc, 2013)

Potential role of vitamin D in the elderly to resist COVID-19 and to slow progression of Parkinson’s disease - Hribar, C. A.; Cobbold, P. H.; Church, F. C. (Brain Sci, 2020)

Effect of vitamin D status on adult COVID-19 pneumonia induced by delta variant: a longitudinal, real-world cohort study - Huang, H.; Zheng, J.; Liu, Y.; Zhou, Q.; Peng, D. (Front Med, 2023)

COVID-19 and diabetes: knowledge in progress - Hussain, A.; Bhowmik, B.; do Vale Moreira, N. C. (Diabetes Res Clin Pract, 2020)

Strengthening the immune system and reducing inflammation and oxidative stress through diet and nutrition: considerations during the COVID-19 crisis - Iddir, M.; Brito, A.; Dingeo, G.; Fernandez Del Campo, S. S.; Samouda, H.; Frano, M. R. (Nutrients, 2020)

Institute of Medicine Committee to Review Dietary Reference Intakes for Vitamin D, Calcium (2011) The National Academies Collection: reports funded by National Institutes of Health. In: Ross AC, Taylor CL, Yaktine AL, Del Valle HB, editors. Dietary reference intakes for calcium and vitamin D. Washington (DC): National Academies Press (US) Copyright © 2011, National Academy of Sciences

Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients - Ish-Shalom, S.; Segal, E.; Salganik, T.; Raz, B.; Bromberg, I. L.; Vieth, R. (J Clin Endocrinol Metab, 2008)

Vitamin D, infections and immunity - Ismailova, A.; White, J. H. (Rev Endocr Metab Disord, 2022)

Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers - Jain, A.; Chaurasia, R.; Sengar, N. S.; Singh, M.; Mahor, S.; Narain, S. (Sci Rep, 2020)

Vitamin D in plants: a review of occurrence, analysis, and biosynthesis - Jäpelt, R. B.; Jakobsen, J. (Front Plant Sci, 2013)

Effect of single high dose vitamin D substitution in hospitalized COVID-19 patients with vitamin D deficiency on length of hospital stay - Jaun, F.; Boesing, M.; Luethi-Corridori, G.; Abig, K.; Bloch, N.; Giezendanner, S. (Biomedicines, 2023)

Pharmacokinetics of vitamin D toxicity - Jones, G. (Am J Clin Nutr, 2008)

25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D - Jones, G.; Prosser, D. E.; Kaufmann, M. (Arch Biochem Biophys, 2012)

Vitamin D deficiency and risk for cardiovascular disease - Judd, S. E.; Tangpricha, V. (Am J Med Sci, 2009)

Why the elderly appear to be more severely affected by COVID-19: the potential role of immunosenescence and CMV - Kadambari, S.; Klenerman, P.; Pollard, A. J. (Rev Med Virol, 2020)

Impact of serum 25 (OH) vitamin D level on mortality in patients with COVID-19 in Turkey - Karahan, S.; Katkat, F. (J Nutr Health Aging, 2021)

SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels - Kaufman, H. W.; Niles, J. K.; Kroll, M. H.; Bi, C.; Holick, M. F. (PLoS ONE, 2020)

Vitamin D deficiency in adults: when to test and how to treat - Kennel, K. A.; Drake, M. T.; Hurley, D. L. (Mayo Clin Proc, 2010)

Coronavirus diseases 2019: current biological situation and potential therapeutic perspective - Khan, S.; Tombuloglu, H.; Hassanein, S. E.; Rehman, S.; Bozkurt, A.; Cevik, E. (Eur J Pharmacol, 2020)

Calcium and vitamin D: skeletal and extraskeletal health - Khazai, N.; Judd, S. E.; Tangpricha, V. (Curr Rheumatol Rep, 2008)

Vitamin D deficiency and risk of cardiovascular diseases: a narrative review - Kheiri, B.; Abdalla, A.; Osman, M.; Ahmed, S.; Hassan, M.; Bachuwa, G. (Clin Hypertens, 2018)

Vitamin D supplementation in influenza and COVID-19 infections comment on: “Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths” nutrients 2020, 12 (4), 988 - Kow, C. S.; Hadi, M. A.; Hasan, S. S. (Nutrients, 2020)

Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19 - Kumar, R.; Rathi, H.; Haq, A.; Wimalawansa, S. J.; Sharma, A. (Virus Res, 2021)

Impact of daily high dose oral vitamin D therapy on the inflammatory markers in patients with COVID 19 disease - Lakkireddy, M.; Gadiga, S.; Malathi, R.; Karra, M.; Prasad Murthy Raju, I. S. S. V. (Sci Rep, 2021)

Vitamin D insufficiency is prevalent in severe COVID-19 - Lau, F. H.; Majumder, R.; Torabi, R.; Saeg, F.; Hoffman, R.; Cirillo, J. D. (MedRxiv, 2020)

Screening for vitamin D deficiency in adults: U.S. Preventive Services Task Force recommendation statement - LeFevre, M. L. (Ann Intern Med, 2015)

Aging decreases the capacity of human skin to produce vitamin D3 - MacLaughlin, J.; Holick, M. F. (J Clin Invest, 1985)

Treatment with 25-hydroxyvitamin D3 (calcifediol) is associated with a reduction in the blood neutrophil-to-lymphocyte ratio marker of disease severity in hospitalized patients with COVID-19: a pilot multicenter, randomized, placebo-controlled, double-blinded clinical trial - Maghbooli, Z.; Sahraian, M. A.; Jamalimoghadamsiahkali, S.; Asadi, A.; Zarei, A.; Zendehdel, A. (Endocr Pract, 2021)

Redefining vitamin D insufficiency - Malabanan, A.; Veronikis, I. E.; Holick, M. F. (Lancet, 1998)

Interaction of the vitamin D receptor with a vitamin D response element in the Müllerian-inhibiting substance (MIS) promoter: regulation of MIS expression by calcitriol in prostate cancer cells - Malloy, P. J.; Peng, L.; Wang, J.; Feldman, D. (Endocrinology, 2009)

Vitamin D deficiency and anemia is highly prevalent and dependent on the etiology of heart failure: a pilot study - Małyszko, J.; Tomaszuk-Kazberuk, A.; Dobrzycki, K.; Bachórzewska-Gajewska, H.; Zorawski, M.; Koc-Zorawska, E. (Cardiol J, 2019)

Strong association between vitamin D receptor gene and severe acute respiratory syndrome coronavirus 2 infectious variants - Mamurova, B.; Akan, G.; Mogol, E.; Turgay, A.; Tuncel, G.; Evren, E. U. (Glob Med Genet, 2023)

Vitamin D deficiency—is there really a pandemic? - Manson, J. E.; Brannon, P. M.; Rosen, C. J.; Taylor, C. L. (N Engl J Med, 2016)

Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis - Martineau, A. R.; Jolliffe, D. A.; Greenberg, L.; Aloia, J. F.; Bergman, P.; Dubnov-Raz, G. (Health Technol Assess, 2019)

Clinical implications of vitamin D deficiency - Matyjaszek-Matuszek, B.; Lenart-Lipińska, M.; Woźniakowska, E. (Menopause Rev, 2015)

Is serum 25-hydroxyvitamin d level associated with severity of COVID-19? A retrospective study - Mbata, M. K.; Hunziker, M.; Makhdoomi, A.; Lüthi-Corridori, G.; Boesing, M.; Giezendanner, S. (J Clin Med, 2023)

Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis - Meckel, K.; Li, Y. C.; Lim, J.; Kocherginsky, M.; Weber, C.; Almoghrabi, A. (Am J Clin Nutr, 2016)

The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of “inflame-aging” - Meftahi, G. H.; Jangravi, Z.; Sahraei, H.; Bahari, Z. (Inflamm Res, 2020)

Evidence regarding vitamin D and risk of COVID-19 and its severity - Mercola, J.; Grant, W. B.; Wagner, C. L. (Nutrients, 2020)

Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study - Merzon, E.; Tworowski, D.; Gorohovski, A.; Vinker, S.; Golan Cohen, A.; Green, I. (FEBS J, 2020)

Clinical course and management of COVID-19 in the era of widespread population immunity - Meyerowitz, E. A.; Scott, J.; Richterman, A.; Male, V.; Cevik, M. (Nat Rev Microbiol, 2024)

Vitamin D deficiency: a new risk factor for type 2 diabetes? - Mezza, T.; Muscogiuri, G.; Sorice, G. P.; Prioletta, A.; Salomone, E.; Pontecorvi, A. (Ann Nutr Metab, 2012)

The study of vitamin D administration effect on CRP and Interleukin-6 as prognostic biomarkers of ventilator associated pneumonia - Miroliaee, A. E.; Salamzadeh, J.; Shokouhi, S.; Sahraei, Z. (J Crit Care, 2018)

The vitamin D sterol-vitamin D receptor ensemble model offers unique insights into both genomic and rapid-response signaling - Mizwicki, M. T.; Norman, A. W. (Sci Signal, 2009)

Exploring links between vitamin D deficiency and COVID-19 - Mohan, M.; Cherian, J. J.; Sharma, A. (PLoS Pathog, 2020)

Vitamin D receptor agonists specifically modulate the volume of the ligand-binding pocket - Molnár, F.; Peräkylä, M.; Carlberg, C. (J Biol Chem, 2006)

1α,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: its synthesis, biological activity and crystal structure with its receptor - Molnár, F.; Sigüeiro, R.; Sato, Y.; Araujo, C.; Schuster, I.; Antony, P. (PLoS ONE, 2011)

Taking vitamin D with the largest meal improves absorption and results in higher serum levels of 25-hydroxyvitamin D - Mulligan, G. B.; Licata, A. (J Bone Miner Res, 2010)

Effect of vitamin D3 supplementation vs placebo on hospital length of stay in patients with severe COVID-19: a multicenter, double-blind, randomized controlled trial - Murai, I. H.; Fernandes, A. L.; Sales, L. P.; Pinto, A. J.; Goessler, K. F.; Duran, C. S. (Medrxiv, 2020)

Noncalcemic actions of vitamin D receptor ligands - Nagpal, S.; Na, S.; Rathnachalam, R. (Endocr Rev, 2005)

Cellular senescence as a potential mediator of COVID-19 severity in the elderly - Nehme, J.; Borghesan, M.; Mackedenski, S.; Bird, T. G.; Demaria, M. (Aging Cell, 2020)

Paxlovid: a promising drug for the challenging treatment of SARS-COV-2 in the pandemic era - Niraj, N.; Mahajan, S. S.; Prakash, A.; Sarma, P.; Medhi, B. (Indian J Pharmacol, 2022)

Minireview: vitamin D receptor: new assignments for an already busy receptor - Norman, A. W. (Endocrinology, 2006)

From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health - Norman, A. W. (Am J Clin Nutr, 2008)

Vitamin D and its effects on DNA methylation in development, aging, and disease - Ong, L. T. C.; Booth, D. R.; Parnell, G. P. (Mol Nutr Food Res., 2020)

Vitamin D levels and intensive care unit outcomes of a cohort of critically ill COVID-19 patients - Orchard, L.; Baldry, M.; Nasim-Mohi, M.; Monck, C.; Saeed, K.; Grocott, M. P. W. (Clin Chem Lab Med, 2021)

An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19 - Owen, D. R.; Allerton, C. M. N.; Anderson, A. S.; Aschenbrenner, L.; Avery, M.; Berritt, S. (Science, 2021)

COVID-19 and diabetes mellitus: an unholy interaction of two pandemics - Pal, R.; Bhadada, S. K. (Diabetes Metab Syndr, 2020)

Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity - Panagiotou, G.; Tee, S. A.; Ihsan, Y.; Athar, W.; Marchitelli, G.; Kelly, D. (Clin Endocrinol, 2020)

Vitamin D levels and clinical outcomes of SARS-CoV-2 Omicron subvariant BA.2 in children: a longitudinal cohort study - Peng, D.; Huang, H.; Liu, Z.; Gao, Y.; Liu, Y. (Front Nutr, 2022)

Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis - Pereira, M.; Dantas Damascena, A.; Galvão Azevedo, L. M.; Almeida, O. l. i. v. e. i. r. a. T.; Mota, S. a. n. t. a. n. a. J. (Crit Rev Food Sci Nutr, 2020)

COVID-19 and the elderly: insights into pathogenesis and clinical decision-making - Perrotta, F.; Corbi, G.; Mazzeo, G.; Boccia, M.; Aronne, L.; D’Agnano, V. (Aging Clin Exp Res, 2020)

The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D(3) - Pike, J. W.; Meyer, M. B. (Endocrinol Metab Clin North Am, 2010)

Vitamin D and immune function - Prietl, B.; Treiber, G.; Pieber, T. R.; Amrein, K. (Nutrients, 2013)

Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study) - Rastogi, A.; Bhansali, A.; Khare, N.; Suri, V.; Yaddanapudi, N.; Sachdeva, N. (Postgrad Med J, 2022)

Current scenario of COVID-19 in pediatric age group and physiology of immune and thymus response - Rehman, S.; Majeed, T.; Azam Ansari, M.; Ali, U.; Sabit, H.; Al-Suhaimi, E. A. (Saudi J Biol Sci, 2020)

Perspective: vitamin D deficiency and COVID-19 severity—plausibly linked by latitude, ethnicity, impacts on cytokines, ACE 2 and thrombosis - Rhodes, J. M.; Subramanian, S.; Laird, E.; Griffin, G.; Kenny, R. A. (J Intern Med, 2021)

Perspective: vitamin D deficiency and COVID-19 severity – plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2 and thrombosis - Rhodes, J. M.; Subramanian, S.; Laird, E.; Griffin, G.; Kenny, R. A. (J Intern Med, 2021)

Prevalence of vitamin D deficiency and its associations with skin color in pregnant women in the first trimester in a sample from Switzerland - Richard, A.; Rohrmann, S.; Quack Lötscher, K. C. (Nutrients, 2017)

IOM committee members respond to Endocrine Society vitamin D guideline - Rosen, C. J.; Abrams, S. A.; Aloia, J. F.; Brannon, P. M.; Clinton, S. K.; Durazo-Arvizu, R. A. (J Clin Endocrinol Metab, 2012)

Effects of a 2-week 5000 IU versus 1000 IU vitamin D3 supplementation on recovery of symptoms in patients with mild to moderate Covid-19: a randomized clinical trial - Sabico, S.; Enani, M. A.; Sheshah, E.; Aljohani, N. J.; Aldisi, D. A.; Alotaibi, N. H. (Nutrients, 2021)

Evidence for the efficacy of a high dose of vitamin D on the hyperinflammation state in moderate-to-severe COVID-19 patients: a randomized clinical trial - Sarhan, N.; Abou Warda, A. E.; Sarhan, R. M.; Boshra, M. S.; Mostafa-Hedeab, G.; ALruwaili, B. F. (Medicina, 2022)

COVID-19 and older adults: what we know - Shahid, Z.; Kalayanamitra, R.; McClafferty, B.; Kepko, D.; Ramgobin, D.; Patel, R. (J Am Geriatr Soc, 2020)

Unraveling the roles of vitamin D status and melanin during Covid-19 (review) - Sidiropoulou, P.; Docea, A. O.; Nikolaou, V.; Katsarou, M. S.; Spandidos, D. A.; Tsatsakis, A. (Int J Mol Med, 2021)

Vitamin D deficiency in patients with diabetes and COVID-19 infection - Singh, S. K.; Jain, R.; Singh, S. (Diabetes Metab Syndr, 2020)

Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations - Singh, A. K.; Gupta, R.; Ghosh, A.; Misra, A. (Diabetes Metab Syndr, 2020)

Vitamin D: a review of its effects on epigenetics and gene regulation - Snegarova, V.; Naydenova, D. (Folia Med, 2020)

Association between low vitamin D and COVID-19: don’t forget the vitamin D binding protein - Speeckaert, M. M.; Delanghe, J. R. (Aging Clin Exp Res, 2020)

Role of vitamin D in insulin resistance - Sung, C. C.; Liao, M. T.; Lu, K. C.; Wu, C. C. (J Biomed Biotechnol, 2012)

Vitamin D: more than a “bone-a-fide” hormone - Sutton, A. L.; MacDonald, P. N. (Mol Endocrinol, 2003)

The molecular mechanisms by which vitamin D prevents insulin resistance and associated disorders - Szymczak-Pajor, I.; Drzewoski, J.; Śliwińska, A. (Int J Mol Sci, 2020)

A cohort study to evaluate the effect of combination vitamin D, magnesium and vitamin B12 (DMB) on progression to severe outcome in older COVID-19 patients - Tan, C. W.; Ho, L. P.; Kalimuddin, S.; Cherng, B. P. Z.; Teh, Y. E.; Thien, S. Y. (MedRxiv, 2020)

Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis - Tang, B. M.; Eslick, G. D.; Nowson, C.; Smith, C.; Bensoussan, A. (Lancet, 2007)

Recent advances in solar still technology for solar water desalination - Tony, M. A.; Nabwey, H. A. (Appl Water Sci, 2024)

The physiology of vitamin D receptor activation - Valdivielso, J. M. (Contrib Nephrol, 2009)

Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts - Etten, E.; Mathieu, C. (J Steroid Biochem Mol Biol, 2005)

Low 25-hydroxyvitamin D levels on admission to the intensive care unit may predispose COVID-19 pneumonia patients to a higher 28-day mortality risk: a pilot study on a Greek ICU cohort - Vassiliou, A. G.; Jahaj, E.; Pratikaki, M.; Orfanos, S. E.; Dimopoulou, I.; Kotanidou, A. (Nutrients, 2020)

Vitamin D, calcium homeostasis and aging - Veldurthy, V.; Wei, R.; Oz, L.; Dhawan, P.; Jeon, Y. H.; Christakos, S. (Bone Res, 2016)

Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety - Vieth, R. (Am J Clin Nutr, 1999)

Meta-analysis of vitamin D supplementation in the treatment of chronic heart failure - Wang, T.; Liu, Z.; Fu, J.; Min, Z. (Scand Cardiovasc J, 2019)

Vitamin D and the dual processes of intestinal calcium absorption - Wasserman, R. H. (J Nutr, 2004)

Oxytetracycline reduces inflammation and treponeme burden whereas vitamin D 3 promotes β-defensin expression in bovine infectious digital dermatitis - Watts, K. M.; Lahiri, P.; Arrazuria, R.; Buck, J.; Knight, C. G.; Orsel, K. (Cell Tissue Res, 2020)

Who, what, where and when—influences on cutaneous vitamin D synthesis - Webb, A. R. (Prog Biophys Mol Biol, 2006)

Does vitamin D deficiency increase the severity of COVID-19? - Weir, E. K.; Thenappan, T.; Bhargava, M.; Chen, Y. (Clin Med, 2020)

Dietary magnesium may be protective for aging of bone and skeletal muscle in middle and younger older age men and women: cross-sectional findings from the UK Biobank cohort - Welch, A. A.; Skinner, J.; Hickson, M. (Nutrients, 2017)

Deficiency: effects on oxidative stress, epigenetics, gene regulation, and aging - Wimalawansa, S. J.; Vitamin, D. (Biology, 2019)

Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system - Xu, J.; Yang, J.; Chen, J.; Luo, Q.; Zhang, Q.; Zhang, H. (Mol Med Rep, 2017)

Does serum vitamin D level affect COVID-19 infection and its severity?—A case-control study - Ye, K.; Tang, F.; Liao, X.; Shaw, B. A.; Deng, M.; Huang, G. (J Am Coll Nutr, 2021)

Effects of vitamin D on COVID-19 infection and prognosis: a systematic review - Yisak, H.; Ewunetei, A.; Kefale, B.; Mamuye, M.; Teshome, F.; Ambaw, B. (Risk Manag Healthc Policy, 2021)

Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1 - Zhang, Y.; Leung, D. Y.; Richers, B. N.; Liu, Y.; Remigio, L. K.; Riches, D. W. (J Immunol, 2012)

Vitamin D and alternative splicing of RNA - Zhou, R.; Chun, R. F.; Lisse, T. S.; Garcia, A. J.; Xu, J.; Adams, J. S. (J Steroid Biochem Mol Biol, 2015)

CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo - Zhu, J. G.; Ochalek, J. T.; Kaufmann, M.; Jones, G.; Deluca, H. F. (Proc Natl Acad Sci U S A, 2013)

Vitamin D insufficiency in congestive heart failure: why and what to do about it? - Zittermann, A.; Schleithoff, S. S.; Koerfer, R. (Heart Fail Rev, 2006)